Screener
Charles River Laboratories CRL Manufacturing — Goodwill, impaired, accumulated impairment loss
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Charles River Laboratories in its filing.
Tagged under the XBRL concept us-gaap:GoodwillImpairedAccumulatedImpairmentLoss.
The source filing: Charles River Laboratories’s 10-Q, filed August 5, 2026. Open the filing →
- Filed
- Aug 5, 2026, 9:21 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001100682-26-000118
FAQ
- What is Charles River Laboratories's manufacturing — goodwill, impaired, accumulated impairment loss?
- Charles River Laboratories (CRL) reported manufacturing — goodwill, impaired, accumulated impairment loss of $380M in Q2 2026.
- How has Charles River Laboratories's manufacturing — goodwill, impaired, accumulated impairment loss changed year-over-year?
- Charles River Laboratories's manufacturing — goodwill, impaired, accumulated impairment loss increased by 76.7% year-over-year, from $215M to $380M.
- What does manufacturing — goodwill, impaired, accumulated impairment loss mean?
- The cumulative total of impairment charges recognized against goodwill specifically allocated to the manufacturing segment. This reflects historical write-downs due to the carrying value of the segment exceeding its fair value.
Ask your AI about Charles River Laboratories's manufacturing — goodwill, impaired, accumulated impairment loss.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI

Claude